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Abstract
A variety of tests of sensorimotor function are used to characterize outcome after experimental spinal cord injury (SCI). These tests
typically do not provide information about chemical and metabolic processes in the injured CNS. Here, we used
1H-magnetic
resonance spectroscopy (MRS) to monitor long-term and short-term chemical changes in the CNS in vivo following SCI. The
investigated areas were cortex, thalamus⁄striatum and the spinal cord distal to injury. In cortex, glutamate (Glu) decreased 1 day
after SCI and slowly returned towards normal levels. The combined glutamine (Gln) and Glu signal was similarly decreased in cortex,
but increased in the distal spinal cord, suggesting opposite changes of the Glu⁄Gln metabolites in cortex and distal spinal cord. In
lumbar spinal cord, a marked increase of myo-inositol was found 3 days, 14 days and 4 months after SCI. Changes in metabolite
concentrations in the spinal cord were also found for choline and N-acetylaspartate. No signiﬁcant changes in metabolite
concentrations were found in thalamus⁄striatum. Multivariate data analysis allowed separation between rats with SCI and controls for
spectra acquired in cortex and spinal cord, but not in thalamus⁄striatum. Our ﬁndings suggest MRS could become a helpful tool to
monitor spatial and temporal alterations of metabolic conditions in vivo in the brain and spinal cord after SCI. We provide evidence for
dynamic temporal changes at both ends of the neuraxis, cortex cerebri and distal spinal cord, while deep brain areas appear less
affected.
Introduction
Spinal cord injury (SCI) leads to tissue damage with local cell death,
demyelination and disruption of axon pathways. Primary injury is
followed by an extended period of secondary injury, which may
exacerbate the ensuing functional deﬁcits. This process includes
inﬂammation, ischaemia, free radical-induced cell death, glutamate
(Glu) excitotoxicity and local tissue remodelling (for reviews, see:
secondary injury: Tator & Fehlings, 1991; Park et al., 2004; inﬂam-
mation: Popovich et al., 1997; Popovich & Longbrake, 2008; free
radicals and lipid peroxidation: Demopoulos et al., 1980; complement
activation: Hagg & Oudega, 2006; ischaemia: Tator & Koyanagi, 1997;
excitotoxicity: Park et al., 2004; astrogliosis⁄scar: Fawcett & Asher,
1999; Silver & Miller, 2004). Neuroprotective processes and regen-
erative reactions are also initiated (Hagg & Oudega, 2006; Maier &
Schwab, 2006). A degree of spontaneous recovery is typically seen
after partial injury to the spinal cord (Narayana et al., 2004). Because
cut axons in the adult mammalian CNS typically do not regenerate
(Olson, 1997), such recovery is thought to be due to reversal of the
spinal shock state and reorganization of existing circuitries both in
spinal cord and brain (Frigon & Rossignol, 2006).
Plastic changes after SCI occur in the spinal cord itself, but also in
the brain, including cortex and thalamus (Fouad et al., 2001;
Hofstetter et al., 2003; Kerschensteiner et al., 2005; Bradbury &
McMahon, 2006; Ramu et al., 2007). In the spinal cord, early
degenerative changes have been observed within minutes after injury,
and regenerative sprouting within 6–24 h. Later, reactive astrogliosis
follows, thought to help prevent inﬂammatory events by containing
the damaged zone, protecting spared tissue and helping re-establish
the blood–spinal cord barrier (Faulkner et al., 2004). However, this
astrocytic scar also contributes to the prevention of axon regeneration
(Silver & Miller, 2004).
Magnetic resonance spectroscopy (MRS) is a non-invasive tech-
nique allowing metabolic proﬁles from CNS areas to be obtained
in vivo.
1H-MRS has been used to study metabolic changes after SCI
in motor cortex (Puri et al., 1998) and thalamus of patients (Pattany
et al., 2002) and rats (Likavcanova et al., 2008).
1H-MRS of the
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2000; Cooke et al., 2004; Henning et al., 2008) and in rats (Vink
et al., 1989a; Zelaya et al., 1996; Silver et al., 2001; Balla & Faber,
2007; Qian et al., 2010).
31P MRS of the spinal cord has been used to
investigate metabolic changes after SCI in rabbits (Vink et al.,
1989a,b) and pigs (Akino et al., 1997). In this study, metabolic
changes were monitored by
1H-MRS in acute and chronic SCI, in
cortex cerebri, thalamus⁄striatum and the spinal cord below injury.
Group differences were found for speciﬁc metabolites. Because our
work monitors acute as well as chronic changes simultaneously in
distal spinal cord, thalamus⁄striatum and cortex, we can conclude that
SCI leads to metabolic changes at several different levels of the
neuraxis, and that there are differences between the acute and chronic
condition.
Materials and methods
SCI
All experiments were performed according to procedures approved by
the Stockholm animal ethics committee. Twenty-eight female adult
Sprague–Dawley rats (180–250 g) were operated under isoﬂurane
anaesthesia. Brieﬂy, skin and muscles were opened and a laminectomy
was performed at vertebral level T9. After exposure of the spinal cord,
a 3-mm-long segment of the spinal cord was removed with a sharp
knife, in order to assure complete transection. Muscles and skin were
sutured. After surgery, rats were placed on heating pads and received
analgesics (buprenorphine, Temgesic, Schering-Plough, Kenilworth,
NJ, USA) and antibiotics (Borgal, Hoechst, Warren, NJ, USA) to
prevent infections. Assisted bladder emptying was performed twice
daily as long as needed. As expected, rats only recovered minimal,
presumably reﬂexive, movements of an occasional joint in the hind
limbs, corresponding to a Basso–Beattie–Bresnahan locomotor score
below 1 (Basso et al., 1995). Animals were kept from 1 day to
4 months before being killed.
1H-MRS
Individual rats were scanned using
1H-MRS at several time points
(Table 1), starting with naı ¨ve control rats. Anaesthesia was induced
with isoﬂurane and maintained during scans by spontaneous breathing
of 2% isoﬂurane. Rats were positioned in supine position and ﬁxed to
an acrylic rig. Pulse was monitored, and body temperature kept at
37 ± 0.5 ºC with a warm laminar air stream.
Table 1 presents an overview of groups of animals, time points and
areas from which spectra were acquired. Four different volumes of
interest (VOIs) were investigated (Fig. 1), positioned in the cerebral
cortex (two VOIs), thalamus⁄striatum and lumbar spinal cord,
respectively. Spectra from all four VOIs were not acquired from the
same groups of animals, as stated in Table 1. The cortical analysis was
subdivided into a bilateral cortical VOI and a smaller unilateral
parietal cortex VOI. The bilateral cortex VOI (72 lL) was placed in
the centre of the brain, including motor cortex of both hemispheres,
and adjusted so as not to include subdural space, 5 mm behind the
rhinal ﬁssure (Fig. 1). This VOI was used to monitor short-term and
long-term metabolic changes. The unilateral cortex VOI (18 lL) was
centred over the sensorimotor area of the hind limbs (Fig. 1), based on
previous results from functional magnetic resonance imaging (MRI;
Hofstetter et al., 2003; Endo et al., 2007) to investigate short-term
changes. Another VOI (76 lL), including thalamus⁄striatum and
located in the deep centre of the brain, was used to study long-term
changes. This VOI was placed 9.0 mm behind the rhinal ﬁssure,
positioned between the lateral ventricles (Fig. 1). Spectra were also
acquired from a 16-lL VOI in the lumbar spinal cord beneath injury,
to monitor both short-term and long-term changes. This VOI was
placed ﬁve segments below the lesion (Fig. 1). At this level the
volume of the rat spinal cord (white and grey matter together), and the
proximity of the spinal cord tissue to the body surface allowed
reproducible MRS data to be obtained. Using the 13th rib as a
landmark, the appropriate level of the spinal cord (Fraidakis et al.,
1998) was located. Whenever possible, the VOI was centred between
two intervertebral discs, avoiding inclusion of bone lining the
vertebral canal and the large vessels on the dorsal and ventral side.
All experiments were performed using a horizontal 4.7 T⁄40 cm
magnet (BioSpec Avance 47⁄40; Bruker, Ettlingen, Germany)
equipped with a 12-cm inner diameter self-shielded gradient system
(maximum gradient strength 200 mT⁄m). A linear birdcage resonator
(Bruker, Ettlingen, Germany) with an inner diameter of 35 mm was
used for excitation and reception to acquire bilateral cortex and
thalamus⁄striatum spectra). A 72-mm birdcage resonator for trans-
mission and a ‘rat brain’ quadrature receiver coil (Bruker, Ettlingen,
Germany) secured to the animal holder above the head was used to
acquire the unilateral cortex VOI spectra. For the spinal cord, a surface
coil (T9510; Bruker, Ettlingen, Germany) with an inner diameter of
20 mm was used for transmission and detection. B0 was optimized at
the VOI using linear shims.
Voxel shape and localization was achieved by point-resolved
spectroscopy (PRESS) using Hermite radiofrequency pulses with
matched bandwidths of 5.4 kHz. The voxel displacement due to
chemical shift to the peaks discussed in this work can then be
estimated to be 8%. The PRESS sequence was applied with the
following parameters: repetition time (TR): 3500 ms; echo time (TE):
16 ms for the unilateral cortex VOI and 20 ms for the other VOIs;
spectral width: 2 kHz; and number of acquired complex points: 2048.
Reliable water suppression was achieved by VAPOR (Tkac et al.,
1999) due mainly to its immunity to B1 inhomogeneities. Thala-
mus⁄striatum and bilateral cortex spectra were obtained with number
of transients (NT): 256 (15 min); unilateral cortex and spinal cord
using NT: 512 (30 min). Positions of the VOIs were based on
multislice RARE images in axial, sagittal and coronal planes with the
following parameters: effective TE: 37.4⁄25.4 ms for brain⁄spinal
cord; TR: 2500 ms; RARE factor: 8⁄4 for brain⁄spinal cord; spatial
resolution: 156 · 156 lm
2; slice thickness: 1 mm; and number of
averages: 1⁄2 for brain⁄spinal cord, respectively.
Quantiﬁcation
The software package LCModel (Provencher,1993, 2001) was used for
metabolite quantiﬁcation (Supporting Information Fig. S1). The
quantiﬁcation algorithm of LCModel applies a non-linear regression
Table 1. Overview of animals studied at different time points
Time after SCI
Brain
Spinal cord
Bilateral
cortex Thalamus
Unilateral
cortex
Naı ¨ve control Rat 1–10 Rat 1–10 Rat 21–28 Rat 11–20
1 day Rat 11–20 Rat 21–28 Rat 11–20
3 days Rat 11–20 Rat 21–28 Rat 11–20
14 days Rat 11–20
3 months Rat 1–10 Rat 1–10
4 months Rat 1–10 Rat 1–10 Rat 1–10
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study was to simultaneously monitor metabolic changes over time in
the brain and in the spinal cord. Oedema in the spinal cord after SCI
biased the quantiﬁcation relative to water, and therefore metabolite
concentrations from all VOIs were quantiﬁed relative to total creatine
[tCR; creatine (Cr) + phosphocreatine (PCr)]. The following 18
metabolites were included in the basis set: alanine, aspartate, Cr,
-CrCH2 (correction term), c-aminobutyric acid (GABA), glucose, Glu,
glutamine (Gln), glycerophosphocholine (GPC), guanidoacetate (Gua),
phosphocholine (PCh), myo-inositol (Ins), lactate, N-acetylaspartate
(NAA), N-acetylaspartylglutamate (NAAG), PCr, scyllo-inositol,
taurine, macromolecules and lipids. Spectral data associated with
Crame ´r–Rao lower bounds (CRLB) ‡ 20% were excluded from further
analysis.
Statistical analysis
The SPSS software package (SPSS, Chicago, IL, USA) was used for
statistical analysis. Data for each metabolite were tested for normal
distribution (Kolmogorov–Smirnov test) and for homogeneity of
variances. The data were then analysed VOI-wise by multivariate
analysis of variance (manova; Pillai’s trace) followed by separate
univariate analysis of variance (anova) on the metabolites. In order to
ﬁnd out which groups (time points) differed, post hoc tests (Tukey)
were applied. Data were also investigated with multivariate data
analysis (MVDA) using appropriate software (SIMCA; Umetrics AB,
Umea ˚, Sweden). Two MVDA methods were applied: principal
components analysis (PCA) and partial least squares projections to
latent structures – discriminant analysis (PLS-DA). Before PCA and
PLS-DA, the data were mean-centred and scaled to unit variance.
PCA is a multivariate projection method designed to extract
systematic variation in data. It is useful to recognize patterns including
outliers, trends and groups. PCA transforms an original set of
correlated variables to a new set of uncorrelated variables, called
principal components. The ﬁrst principal component (t[1]) best
approximates the data in a least squares sense and represents the
maximum variance direction in the data. A second principal compo-
nent (t[2]) is computed in a direction that is orthogonal to t[1] and
reﬂects the second largest source of variation. The components are
obtained in order of decreasing importance, the aim being to reduce
Bilateral cortex VOI = 6.0 × 2.0 × 6.0 mm3
Thalamus/striatum VOI = 6.0 × 3.5 × 3.6 mm3
Spinal cord VOI = 2.3 × 1.4 × 5.0 mm3
Unilateral cortex VOI = 4.0 × 1.5 × 3.0 mm3
VOI = 72 μL
NT = 256
VOI = 16 μL
NT = 512
VOI = 18 μL
NT = 512
VOI = 76 μL
NT = 256
1.0 2.0 3.0 ppm 4.0
Fig. 1. Multislice RARE images of the rat brain with the volumes of interest (VOIs) bilaterally in the cerebral cortex, thalamus ⁄ striatum, unilaterally in cerebral
cortex and spinal cord, and representative in vivo
1H-MRS measured from the corresponding brain regions. RARE MRI; in plane resolution: 156 · 156 lm; slice
thickness: 1 mm; effective TE: 37.4 ⁄ 25.4 ms for brain ⁄ spinal cord; and TR: 2500 ms. Localization sequence PRESS; TE: 16–20 ms; TR: 3500 ms; number of
transients (NT): 256–512 and VOI: 16–76 lL.
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and when the observations are projected on to this plane a two-
dimensional representation (score plot) of the original high-dimen-
sional data is formed. The coordinate values of the observations on
this plane are referred to as scores. Corresponding principal compo-
nent loadings (p[1] and p[2]) can be visualized in order to interpret the
pattern in a score plot. The loadings express the orientation of the
model plane in the variable space.
PLS-DA is a regression extension of PCA. A Y-matrix is formed
that encodes class membership by a set of ‘dummy’ variables (e.g.
group one = 0 and group two = 1). PLS-DA then relates the X-matrix,
containing the observed data, and Y to each other by a linear
multivariate model. The aim of PLS-DA is to create a predictive model
that, using linear combinations of the metabolites, best separate groups
within the data. Here, leave-one-out cross-validation was applied, to
estimate the overall predictive power of the model. The prediction
parameter, Q
2, provides an estimate of the predictive power of a
principal component. For the models built in this study Q
2 needs to be
larger than 0.05. The variable inﬂuence on projection (VIP) param-
eters reﬂect the importance of terms in the model both with respect to
Y, i.e. its correlation to all the responses, and with respect to X (the
projection). Terms with large VIP, larger than 1, are the most relevant
for explaining Y.
Results
Typical locations and sizes of the VOIs centred in bilateral cortex
(mean SNR 14.2), unilateral cortex (mean SNR 8.8), thalamus⁄stri-
atum (mean SNR 12.7) and spinal cord (mean SNR 4.1) are shown in
Fig. 1. Corresponding in vivo
1H-MRS from the brain regions shown
in Fig. 1 represent the spectral quality that was consistently achieved.
Shimming resulted in unsuppressed water signal line widths with a
full-width at half-maximum of 8–16 Hz. When in vivo
1H-MRS were
analysed using LCModel, concentrations of 4–8 metabolites were
reliably quantiﬁed according to CRLB in cortex, thalamus⁄striatum
and spinal cord of control rats and rats with SCI (Fig. 2). Ins, total
choline (tCho), NAA + NAAG (total; tNAA) and Glu + Gln (Glx)
were discernable in spectra from all regions studied. In addition, Glu
was detectable with low CRLBs in all brain spectra, and Gln in
bilateral cortex and thalamus⁄striatum. Moreover, GABA was
detected in thalamus⁄striatum and taurine and Gua in bilateral cortex.
The statistical distributions of data for each metabolite in all studied
regions and at all time points were assessed to be normal (Kolmogo-
rov–Smirnov test). manova revealed signiﬁcant changes over time for
the investigated metabolites for the bilateral cortex VOI (P = 0.040)
and for the spinal cord VOI (P = 0.000), but not for the unilateral
cortex VOI or the VOI in thalamus⁄striatum. Figure 2 presents the
results of metabolite quantiﬁcation from the four VOIs that were used
to study metabolic changes over time. The mean CRLBs correspond-
ing to the quantiﬁed metabolites are also shown in Fig. 2. Asterisks
indicate metabolites for which separate univariate anovas showed
signiﬁcant changes over time. Signiﬁcant differences over time in the
bilateral cortex VOI were found, using anova, for Glu (F4,44 = 3.9,
P = 0.008), tCho (F4,44 = 4.3, P = 0.010) and Glx (F4,43 = 3.5,
P = 0.050). No signiﬁcant changes were found for any of the detected
metabolites in the smaller unilateral VOI in cortex or in the VOI
covering thalamus⁄striatum. In the spinal cord, anova resulted
in signiﬁcant differences between groups for Ins (F4,41 = 9.7,
P = 0.000), tCho (F4,40 = 2.6, P = 0.049), tNAA (F4,41 = 2.6,
P = 0.050) and Glx (F4,41 = 2.9, P = 0.036).
Figure 3 presents metabolite changes over time calculated in
percent of normal (naı ¨ve control rats) for the metabolites that showed
signiﬁcant differences between groups. Asterisks indicate metabolites
for which post hoc tests showed signiﬁcant differences between time
points. A signiﬁcant decrease of Glx (P = 0.013) and Glu (P = 0.007)
was found between controls and rats 1 day after SCI in the bilateral
cortex VOI. Glx in the spinal cord was also found to be signiﬁcantly
different in animals 14 days after SCI compared with both controls
(P = 0.017) and rats 4 months after SCI (P = 0.004). tCho was
changed in both cortex and spinal cord. Signiﬁcant differences were
found between animals 1 day after SCI compared with both 3 days
after SCI (P = 0.011) and 4 months after SCI (P = 0.012) in the
bilateral cortex VOI. tCho showed signiﬁcant (P = 0.049) differences
between groups in the spinal cord with main anova, but not with the
post hoc tests. Ins was signiﬁcantly increased in the spinal cord when
comparing control animals with animals 3 days (P = 0.002), 14 days
(P = 0.046) and 4 months (P = 0.008) after SCI. tNAA showed a
signiﬁcant (P = 0.033) difference between animals 1 day after SCI
compared with 3 days after SCI in the spinal cord.
In order to further explore the data set, PCA was performed as
shown in Fig. 4. Plots were obtained by drawing the scores and
loadings of the ﬁrst two principal components. The score plot is a
summary of the observations (individuals) and the loading plot is a
similar summary of the variables (metabolites). The conﬁdence ellipse
is based on Hotelling T
2, at signiﬁcance level 0.05. Observations
situated outside the ellipse are considered to be outliers. Each plot
mark in the score plots corresponds to one individual and all the
metabolite values that were detected for this individual. Plot marks
close to each other have similar properties. In Fig. 4 the PCA score
plot and corresponding loading plot include data from control animals
and animals with SCI from the four investigated VOIs and all time
points. Only metabolites that were reliably detected for all the four
VOIs as shown in Fig. 2 were included. PCA gave a model, in which
the ﬁrst two principal components explained 75% of the variation in
the data. The more important component is t[1], which separates brain
spectra from spectra in the spinal cord. A PCA score plot and a PCA
loading plot are complementary and superimposable. The loading plot
shows which metabolites are inﬂuential and how the metabolites are
correlated. The further away from the plot origin a variable is, the
stronger impact that variable has on the model. Variables contributing
to similar information are grouped together; they are correlated. In
Fig. 4, Glx and tNAA are grouped together and seem to have similar
properties. They are, together with Ins, important for the separation
between data from the brain and the spinal cord. The t[2] component
demonstrates a difference between thalamus⁄striatum and cortex
spectra. The loading plot demonstrates that tCho is important for this
separation.
It was not successful to build robust PLS-DA models for
classiﬁcations in which data from different VOIs were combined.
The PCA score plot in Fig. 4 might provide an explanation of why.
The data separate into four clusters that can be interpreted as
differences between the four selected CNS areas, but also between the
three brain areas on the one hand and spinal cord data on the other,
between bilateral and unilateral VOIs, and⁄or between the different
coils that were used in this study. These distinctions overshadowed the
differences between classes of animals at different time points. PLS-
DA models for classiﬁcation were therefore built VOI-wise.
Using PLS-DA, no signiﬁcant separation between groups was found
for thalamus⁄striatum VOI. Figure 5 shows PLS-DA score plots of
cortex data comparing control rats with rats 1 day after SCI, 3 days
after SCI, as well as 3 and 4 months after SCI. The model described in
Fig. 5A (one signiﬁcant component and Q
2 = 0.29) resulted in 17⁄20
correctly predicted rats. Three variables were found to have a VIP value
above 1: Glu, Glx and Gua. The model described in Fig. 5B (one
1H-MRS in spinal cord injury 681
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2 = 0.31) resulted in 16⁄20 correctly
predicted rats. Variables with VIP above 1 were Glx, Glu and tNAA. A
model built on data from the unilateral VOI comparing control animals
and animals 3 days after SCI also resulted in a signiﬁcant component
(Q
2 = 0.26 and 12⁄16 correct classiﬁcations). The score plot of this
model is not shown, but the corresponding VIPs are presented below
the VIPs of the bilateral VOI. Variables with the two top VIPs are the
same as for the bilateral cortex VOI: Glx and Glu. The model described
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Fig. 2. Mean concentrations of brain metabolites and corresponding Crame ´r–Rao lower bounds (CRLB) quantiﬁed by LCModel in bilateral cortex, unilateral
cortex, thalamus ⁄ striatum and spinal cord. Concentrations quantiﬁed relative to total creatine (tCr; error bars = SEM) are shown together with corresponding CRLB
expressed in relative units (%). Asterisks indicate metabolites for which signiﬁcant differences were found over time with anova. GABA, c-aminobutyric acid; Gln,
glutamine; Glu, glutamate; Glx, glutamate + glutamine; Gua, guanidoacetate; Ins, myo-inositol; Tau, taurine; tCho, total choline; tNAA, total N-acetylaspartate.
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2 = 0.26) resulted in
14⁄20 correctly predicted rats. Variables with VIP values above 1 were
tNAA, Glu and Glx. The model in Fig. 5D (one signiﬁcant component
and Q
2 = 0.07) resulted in 15⁄19 correctly predicted rats. Variables
with VIP above 1 were taurine, tCho and tNAA.
Figure 6 shows PLS-DA score plots of spinal cord data comparing
control rats with rats 1, 3 and 14 days, and 4 months after SCI. The
model described in Fig. 6A (one signiﬁcant component and
Q
2 = 0.35) resulted in 14⁄20 correctly predicted rats. The variable
with VIP value above 1 was tNAA. The model described in Fig. 6B
(one signiﬁcant component and Q
2 = 0.47) resulted in 15⁄19 correctly
predicted rats. The variable with VIP value above 1 was Ins. The
model described in Fig. 6C (one signiﬁcant component and
Q
2 = 0.32) resulted in 13⁄16 correctly predicted rats. The variables
with VIP values above 1 were Ins and Glx. The model described in
Fig. 6D (one signiﬁcant component and Q
2 = 0.38) resulted in 16⁄18
correctly predicted rats. The variable with VIP value above 1 was Ins.
Discussion
The present study is a detailed evaluation of the possibilities and
limitations of
1H-MRS as a tool to monitor CNS consequences of
SCI in rodents. MVDA allowed separation between rats with SCI
and controls for spectra acquired in cortex and in spinal cord,
demonstrating validity of our approach. We compare acute and
chronic consequences for the brain and lumbar spinal cord of low
thoracic SCI in rats, and ﬁnd that Glx decreases acutely in cortex
and slowly returns to normal levels. Conversely, this metabolite sum
increases in the lumbar spinal cord, in which Glx levels remain
increased 14 days post-injury, but are normalized 4 months after
injury. In cortex, we were able to determine that the Glx decrease
was caused mainly by a decrease in Glu. Additional changes of
1H-MRS-identiﬁable metabolites included alterations of tCho in the
brain and spinal cord, and of Ins and tNAA in the spinal cord. Of
these, the most conspicuous was a marked increase of Ins in the
spinal cord below injury, seen ﬁrst after 3 days and remaining at
4 months, the longest postoperative interval studied. Given the roles
of Ins in intracellular signalling pathways, these observations point
to marked and long-lasting alterations of cell signalling in spinal
cord segments that no longer have bilateral axonal connections with
the rest of the spinal cord and the brain. We found that thalamic and
striatal tissue appeared less affected by the SCI, because no
signiﬁcant changes were identiﬁed in a VOI including these brain
areas.
1H-MRS has been used to evaluate CNS diseases, including
neoplasia, multiple sclerosis, Alzheimer’s disease, Parkinson’s disease
and amyotrophic lateral sclerosis (Lin et al., 2005). For Parkinson’s
disease it was shown that MRS can assist in both diagnosis and
medication of patients (Mueller et al., 2006). Certain metabolites
identiﬁable by MRS have been linked to speciﬁc cell populations.
Thus, NAA is regarded as solely synthesized in neurons (Moffett et al.,
2007), and a decrease is often interpreted as neuronal damage, as found
in multiple sclerosis and Alzheimer’s disease (Lin et al., 2005). In
many diseases, however, it has not yet been possible to detect a speciﬁc
change of a certain metabolite, but rather a complex time-dependent
modulation of several compounds. This led to the concept ‘metabo-
nomics’, deﬁned as ‘the quantitative measurement of the dynamic
multiparametric metabolic response of living systems to pathophysi-
ological stimuli or genetic modiﬁcation’ (Nicholson et al., 1999).
Qian et al. (2010) used
1H-MRS to study rats with traumatically
injured spinal cord. Signiﬁcant changes in NAA, tCr and tCho levels
in segments caudal to the injury were observed. In a study of
metabolic changes in thalamus⁄striatum of rats with SCI (Likavca-
nova et al., 2008), MRS revealed an increase in the levels of NAA, Cr,
Ins and Glu. In sham-operated animals an increase in NAA and Cr
levels was found. Decreased PCr values after SCI have been reported
up to 4 h in rabbits (Vink et al., 1989a) and up to 6 h in pigs (Akino
et al., 1997).
The Glu⁄Gln⁄GABA cycle plays an important role in controlling
levels of the major excitatory neurotransmitter Glu and the major
inhibitory neurotransmitter GABA in the CNS. Gln produced in
astrocytes is taken up by neurons, and converted to Glu or GABA. Glu
released into the synaptic space is recycled by astrocytes. Excitotox-
icity is thought to play a role in the secondary degenerative events that
follow SCI (Faden & Simon, 1988; Wrathall et al., 1994; Agrawal &
Fehlings, 1997; Park et al., 2004), and increased levels of Glu have
been found after SCI at levels neurotoxic even for neurons in the
uninjured spinal cord (Liu et al., 1999). To the extent that the marked
alterations of Glx in the lumbar spinal cord may reﬂect alterations of
Glu, as seems to be the case in cortex, the Glx increase in the spinal
cord could help explain a state of hyperexcitability⁄increased reﬂexes
often noted after SCI. In cortex, the loss of Glu presumably reﬂects
decreased afferent activity, due to loss of input from hind limbs and
other areas below the level of injury.
Ins has a key role in intracellular signalling and has also been
regarded as an osmolite and glial marker (Brand et al., 1993;
Schuhmann et al., 2003), and increases have been interpreted as
increase of glial content or glial proliferation. After SCI, substantial
astrogliosis occurs, and starting within 3 days after injury we found a
signiﬁcant increase of Ins in the spinal cord below injury, which was
maintained throughout the studied postoperative time. This increase
ﬁts with the known long-term increase of glial ﬁbrillary acidic protein-
immunoreactivity in most parts of the spinal cord after injury. For
group comparison of spinal cord spectra, Ins was clearly the most
important metabolite at 3 days and at all later time points. In the brain,
Ins levels were fairly stable, and did not change signiﬁcantly over
time. This is in line with the lack of any marked astroglial responses in
the brain to SCI.
GPC and PCh are the main components of the prominent choline
peak, and constitute metabolites of phospholipid components of
cellular membranes. The size of the choline peak is correlated to
numbers and densities of cells, increased membrane synthesis or
increased membrane breakdown, as in demyelination or glial prolif-
eration (Garnett et al., 2000; Schuhmann et al., 2003). Compared with
the changes of Ins, we found only moderate changes of tCho. We
noted a 16% decrease of tCho in the spinal cord already 1 day after
injury, a time when there was no change of Ins. This suggests that cell
membrane changes occur faster in the spinal cord below injury than
hitherto appreciated, and that astroglial changes occur as a conse-
quence of the massive axonal damage.
NAA is seen as a prominent peak in the MRS, making NAA one of
the most reliable markers for brain MRS studies. Under normal
conditions, NAA is synthesized in and exported from the mitochon-
dria, predominantly in neurons, and hence considered a neuronal
marker for many brain diseases (Moffett et al., 1993, 2007; Tsai &
Coyle, 1995). NAA increases are seen during development (Tkac
et al., 2003), presumably due to neuronal maturation and dendritic
sprouting (van der Knaap et al., 1990). NAA decreases have been
shown by MRS in multiple sclerosis, Alzheimer’s disease and
Parkinson’s disease (Lin et al., 2005; Belli et al., 2006; Yeo et al.,
2006; Moffett et al., 2007). An increase of brain NAA has been found
in patients suffering from Canavan’s disease, a condition in which an
enzyme that breaks down NAA is lacking (Bartalini et al., 1992;
Moffett et al., 2007), thus providing validation of MRS to monitor
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elevations were detected in the cerebral cortex (Puri et al., 1998).
Chromatography-mass spectrometry has also been used to study NAA
concentrations up to 1 week after SCI in rats (Falconer et al., 1996).
Caudal to injury, NAA levels were virtually indistinguishable from
those in control animals. However, despite the wide use of NAA in
MRS, its role in the CNS is not fully understood (Moffett et al., 2007).
We found an increase of NAA in the lumbar enlargement of the spinal
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and might reﬂect a compensatory upregulation, as NAA is considered
to be an important osmolytic regulator for neurons, and⁄or a regulator
of local sprouting. In humans with incomplete SCI (Puri et al., 1998),
50% higher NAA levels were reported 0.5–2 years after injury. The
NAA increase at 1 day in the distal spinal cord in our study may
represent a protective reaction in the form of increased mitochondrial
activity in descending axon arborizations destined to die, leading to a
decrease of NAA at 3 days when nerve terminal degeneration is
ongoing. At later time points (14 days and 4 months) levels were
again somewhat above control levels, possibly the result of increased
activity of local neuronal circuits below injury.
Limitations of the technique as performed in the rat include the
rather inhomogeneous VOI content in the small rodent CNS. Also, we
had to scan ﬁve segments distal to the spinal cord lesion, in order for
the surface coil to be close enough to cord tissue. The current inability
to predict ﬁnal outcome in spinal injury soon after injury limits how
soon after injury novel neuroprotective treatments can be initiated in
patients. Future experiments should help in developing increasingly
better MRS-based prediction for SCI, especially for the early phase,
when it is difﬁcult to predict outcome by other means.
Conclusion
We show that MRS can monitor metabolic changes after SCI, even in
small structures such as the rat spinal cord, and that the method detects
changes distant to the site of primary damage, such as in the cerebral
cortex with good predictability. As the technology develops, MRS
should become helpful in determining the extent of spinal cord
damage and its consequences for the brain, possibly assisting in
differential diagnosis between spinal shock and permanent injury, as
well as for future evaluations of experimental protection and repair
protocols for SCI.
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